keyword
https://read.qxmd.com/read/38473410/impact-of-primary-tumor-location-on-demographics-resectability-outcomes-and-quality-of-life-in-finnish-metastatic-colorectal-cancer-patients-subgroup-analysis-of-the-raxo-study
#21
JOURNAL ARTICLE
Sonja Aho, Emerik Osterlund, Ari Ristimäki, Lasse Nieminen, Jari Sundström, Markus J Mäkinen, Teijo Kuopio, Soili Kytölä, Annika Ålgars, Raija Ristamäki, Eetu Heervä, Raija Kallio, Päivi Halonen, Leena-Maija Soveri, Arno Nordin, Aki Uutela, Tapio Salminen, Hanna Stedt, Annamarja Lamminmäki, Timo Muhonen, Juha Kononen, Bengt Glimelius, Helena Isoniemi, Juho T Lehto, Kaisa Lehtomäki, Pia Osterlund
The primary tumor location (PTL) is associated with the phenotype, metastatic sites, mutations, and outcomes of metastatic colorectal cancer (mCRC) patients, but this has mostly been studied according to sidedness (right vs. left sided). We studied right colon vs. left colon vs. rectal PTL in a real-life study population ( n = 1080). Health-related quality of life (HRQoL) was assessed multi-cross-sectionally with QLQ-C30, QLQ-CR29, EQ-5D, and 15D. A chi-square, Kaplan-Meier, and Cox regression were used to compare the groups...
March 5, 2024: Cancers
https://read.qxmd.com/read/38472291/laser-assisted-pulmonary-metastasectomy-promises-a-low-local-recurrence-rate
#22
JOURNAL ARTICLE
Ahmad Shalabi, Ahmed Ehab, Sundus F Shalabi, Gudrun Kugler, H-J Schäfers, Thomas Graeter
Pulmonary metastasectomy (PM) is consensually performed in a parenchyma-sparing manner to preserve functionally healthy lung tissue. However, this may increase the risk of local recurrence at the surgical margin. Laser assisted pulmonary metastasectomy (LPM) is a relatively recent innovation that is especially useful to resect multiple metastatic pulmonary nodules. In this study we investigated the rate of local recurrence after LPM and evaluated the influence of various clinical and pathological factors on local recurrence...
March 12, 2024: Scientific Reports
https://read.qxmd.com/read/38468341/metastatic-melanoma-to-small-bowel-metastasectomy-is-supported-in-the-era-of-immunotherapy-and-checkpoint-inhibitors
#23
JOURNAL ARTICLE
Paul Wong, Andrew D Wisneski, Katy K Tsai, Tammy T Chang, Kenzo Hirose, Eric K Nakakura, Adil I Daud, Ajay V Maker, Carlos U Corvera
BACKGROUND: Metastatic melanoma to the small bowel is an aggressive disease often accompanied by obstruction, abdominal pain, and gastrointestinal bleeding. With advancements in melanoma treatment, the role for metastasectomy continues to evolve. Inclusion of novel immunotherapeutic agents, such as checkpoint inhibitors, into standard treatment regimens presents potential survival benefits for patients receiving metastasectomy. CASE PRESENTATION: We report an institutional experience of 15 patients (12 male, 3 female) between 2014-2022 that underwent small bowel metastasectomy for metastatic melanoma and received perioperative systemic treatment...
March 11, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38465042/advanced-and-metastatic-gastrointestinal-stromal-tumors-presenting-with-surgical-emergencies-managed-with-surgical-resection-a-case-series
#24
Divij Jayant, Mrinal Goyal, Vipul Thakur, Swapnesh Sahu, Basil Babu, Satish Subbiah Nagaraj, Cherring Tandup, Arunanshu Behera
Advanced and metastatic gastrointestinal stromal tumors (GISTs) presenting with surgical emergencies are rare. Neoadjuvant imatinib being the treatment of choice for non-metastatic advanced disease with a proven role in downstaging the disease may not be feasible in patients presenting with bleeding and obstruction. We present a case series with retrospective analysis of a prospectively maintained database of patients with advanced and metastatic GISTs presenting with surgical emergencies. Clinical characteristics, imaging and endoscopic findings, surgical procedures, histological findings, and outcomes in these patients were studied...
February 2024: Curēus
https://read.qxmd.com/read/38463201/surgical-management-of-metastatic-adrenocortical-carcinoma
#25
JOURNAL ARTICLE
Jesse E Passman, Wajid Amjad, Sara P Ginzberg, Jacqueline M Soegaard Ballester, Caitlin Finn, Heather Wachtel
INTRODUCTION: Adrenocortical carcinoma (ACC) is a notoriously aggressive cancer with a dismal prognosis, especially for patients with metastatic disease. Metastatic ACC is classically a contraindication to operative management. Here, we evaluate the impact of primary tumor resection and metastasectomy on survival in metastatic ACC. METHODS: We performed a retrospective cohort study of patients with metastatic ACC (2010-2019) utilizing the National Cancer Database...
January 2024: World Journal of Surgery
https://read.qxmd.com/read/38440718/increased-expression-of-atp-binding-cassette-transporters-in-enfortumab-vedotin-resistant-urothelial-cancer
#26
Mariko Kotono, Toshiki Kijima, Atsuko Takada-Owada, Naoya Okubo, Ryo Kurashina, Hidetoshi Kokubun, Toshitaka Uematsu, Kohei Takei, Kazuyuki Ishida, Takao Kamai
INTRODUCTION: In addition to reduced nectin-4 expression, the upregulation of ATP-binding cassette transporters has been suggested as a potential mechanism of resistance to enfortumab vedotin. CASE PRESENTATION: A 76-year-old man previously treated with platinum-containing chemotherapy and pembrolizumab for metastatic bladder cancer was administered enfortumab vedotin because of disease progression. Subsequently, metastasectomy was performed for oligometastatic lesions (in the lung and adrenal gland) that exhibited growth during enfortumab vedotin therapy...
March 2024: IJU case reports
https://read.qxmd.com/read/38440717/a-patient-with-oligometastatic-hormone-sensitive-prostate-cancer-who-achieved-long-term-progression-free-survival-following-cytoreductive-radical-prostatectomy-and-metastasectomy
#27
Daisuke Mamiya, Toshiki Kijima, Atsuko Takada-Owada, Hidetoshi Kokubun, Toshitaka Uematsu, Kohei Takei, Tsunehito Kambara, Kazuyuki Ishida, Hiroshi Taneichi, Takao Kamai
INTRODUCTION: Oligometastatic prostate cancer can be well-controlled through combined local and metastasis-directed therapies. However, the effects of cytoreductive radical prostatectomy and metastasectomy remain unclear. CASE PRESENTATION: A 52-year-old man presented with prostate cancer and isolated bone metastasis to the thoracic spine. Six months after neoadjuvant hormonal therapy, the patient underwent cytoreductive radical prostatectomy and total en bloc spondylectomy...
March 2024: IJU case reports
https://read.qxmd.com/read/38435500/renal-cell-carcinoma-with-multiple-bone-metastases-effectively-treated-by-a-combination-of-tyrosine-kinase-inhibitor-robot-assisted-partial-nephrectomy-and-metastasectomy
#28
Atsuro Sawada, Masashi Takeda, Takayuki Goto, Shusuke Akamatsu, Takashi Kobayashi
KEY CLINICAL MESSAGE: Maintaining a disease-free status for a long time in cases of renal cell carcinoma with multiple bone metastases and repeated recurrences is challenging. What matters most in the multidisciplinary approach is the treatment strategy. Although this is a case where multidisciplinary treatment resulted in long-term CR during the TKI era, the treatment strategy is still relevant now that treatment options have increased. ABSTRACT: Recent advances in medications, such as immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs), have improved metastatic renal cell carcinoma (mRCC) outcomes...
March 2024: Clinical Case Reports
https://read.qxmd.com/read/38435446/pulmonary-metastasectomy-after-radiofrequency-ablation-of-hepatocellular-carcinoma
#29
Takahiro Osuga, Shingo Tanaka, Tomohiro Kubo, Kota Hamaguchi, Ryo Ito, Akira Sakurada, Keidai Ishikawa, Koji Miyanishi
INTRODUCTION: Single distant metastases after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC) are rare. There are no guidelines for treating patients without liver tumors after resecting lung metastases. CASE PRESENTATION: Here, we report a patient with HCC recurring as a single lung metastasis 14 months after RFA. A 76-year-old woman with primary biliary cholangitis without hepatitis B virus or hepatitis C virus infection had been treated by RFA for a single 16-mm-sized HCC lesion in liver S8...
2024: Case Reports in Oncology
https://read.qxmd.com/read/38433655/the-impact-of-metastasectomy-on-survival-of-patients-with-synchronous-metastatic-renal-cell-cancer-in-finland-a-nationwide-study
#30
JOURNAL ARTICLE
Lauri Laru, Hanna Ronkainen, Pasi Ohtonen, Markku H Vaarala
BACKGROUND AND OBJECTIVE: Most of the studies on metastasectomy in renal cell cancer are based on metachronous, often oligometastatic disease. Prior data on the impact of metastasectomy in synchronous metastatic renal cell cancer (mRCC) is, however, very scarce. We aimed to investigate the role of complete and incomplete metastasectomy in a large, nationwide patient population. METHODS: We analyzed nationwide data, including all synchronous mRCC cases in Finland diagnosed during a 6-year period identified from the Finnish Cancer Registry, and complemented with patient records from the treating hospitals...
March 4, 2024: Scandinavian Journal of Surgery: SJS
https://read.qxmd.com/read/38429650/radar-guided-localization-and-resection-for-metastatic-nodal-and-soft-tissue-melanoma-a-single-institution-retrospective-study
#31
JOURNAL ARTICLE
Kate E Beekman, Danielle K DePalo, Lily M Parker, Kelly M Elleson, John E Mullinax, Amod A Sarnaik, Vernon K Sondak, Jonathan S Zager
BACKGROUND: Radar-guided localization (RGL) offers a wire-free, nonradioactive surgical guidance method consisting of a small percutaneously-placed radar reflector and handheld probe. This study investigates the feasibility, timing, and outcomes of RGL for melanoma metastasectomy. METHODS: We retrospectively identified patients at our cancer center who underwent RGL resection of metastatic melanoma between December 2020-June 2023. Data pertaining to patients' melanoma history, management, reflector placement and retrieval, and follow-up was extracted from patient charts and analyzed using descriptive statistics...
2024: Cancer Control: Journal of the Moffitt Cancer Center
https://read.qxmd.com/read/38426364/outcomes-and-prognostic-factors-of-repeat-pulmonary-metastasectomy
#32
JOURNAL ARTICLE
Ryu Kanzaki, Hirokazu Watari, Akiisa Omura, Sachi Kawagishi, Ryo Tanaka, Tomohiro Maniwa, Jiro Okami
OBJECTIVES: Information on prognostic factors after repeat pulmonary metastasectomy (PM) is limited, and outcomes after a third PM are not well documented. METHODS: A single-institute retrospective study was conducted. Between 2000 and 2020, 68 patients underwent repeat PM for pulmonary metastases from various cancers. Outcomes and prognostic factors for the second PM and outcomes after the third PM were analyzed. RESULTS: This study included 39 men and 29 women...
February 29, 2024: Interdiscip Cardiovasc Thorac Surg
https://read.qxmd.com/read/38425989/methylated-ctdna-predicts-early-recurrence-risk-in-patients-undergoing-resection-of-initially-unresectable-colorectal-cancer-liver-metastases
#33
JOURNAL ARTICLE
Zhi-Gang Chen, Xiao-Meng Ji, Yu-Xia Xu, William Pat Fong, Xiao-Yun Liu, Jie-Ying Liang, Qiong Tan, Lei Wen, Yan-Yu Cai, De-Shen Wang, Yu-Hong Li
BACKGROUND: Patients with initially unresectable colorectal cancer liver metastases (IU-CRLM) might benefit from using an effective systemic treatment followed by resection of liver metastases but the curative success rate is quite low. Indeed, nearly one-third of patients exhibit early recurrence within the first 6 months after surgery, and these individuals often have poor overall survival. OBJECTIVES: This study aims to clarify the application value of serial circulating tumor DNA (ctDNA) analysis in predicting the clinical outcome of IU-CRLM patients following liver metastasectomy...
2024: Therapeutic Advances in Medical Oncology
https://read.qxmd.com/read/38419310/lung-oligometastasis-of-breast-cancer-prospective-cohort-study-of-treatment-strategies-sbp-06
#34
JOURNAL ARTICLE
Reina Maeda, Tadahiko Shien, Mina Takahashi, Kengo Kawada, Yukiko Kajiwara, Shinichiro Kubo, Daisuke Takabatake, Shoichiro Ohtani, Kinya Matsuoka, Hajime Hikino, Yutaka Ogasawara, Naruto Taira, Shozo Osumi, Masahiko Ikeda, Hiroyoshi Doihara
While local treatment of metastases is considered to be unrelated to prognosis, previous studies have suggested that local treatment of isolated lung metastases may have positive prognostic impact. We designed this prospective cohort study to investigate the clinical situation and its outcomes. We enrolled patients with fewer than 3 lung nodules suspected of being oligometastases after curative breast cancer surgery. Treatments, including local and systemic therapy, were selected by the physician and patient in consultation...
February 2024: Acta Medica Okayama
https://read.qxmd.com/read/38415154/usefulness-of-longitudinal-nodule-matching-algorithm-in-computer-aided-diagnosis-of-new-pulmonary-metastases-on-cancer-surveillance-ct-scans
#35
JOURNAL ARTICLE
Sung Hyun Yoon, Dong Yul Oh, Hyo Jin Kim, Sowon Jang, Minseon Kim, Jihang Kim, Kyung Won Lee, Kyong Joon Lee, Junghoon Kim
BACKGROUND: Detecting new pulmonary metastases by comparing serial computed tomography (CT) scans is crucial, but a repetitive and time-consuming task that burdens the radiologists' workload. This study aimed to evaluate the usefulness of a nodule-matching algorithm with deep learning-based computer-aided detection (DL-CAD) in diagnosing new pulmonary metastases on cancer surveillance CT scans. METHODS: Among patients who underwent pulmonary metastasectomy between 2014 and 2018, 65 new pulmonary metastases missed by interpreting radiologists on cancer surveillance CT (Time 2) were identified after a retrospective comparison with the previous CT (Time 1)...
February 1, 2024: Quantitative Imaging in Medicine and Surgery
https://read.qxmd.com/read/38404407/resection-of-renal-cell-and-prostate-carcinoma-sternum-metastases-with-long-term-follow-up-a-report-of-2-cases
#36
Pascal A Berdat, Paul R Vogt, Pascal A Schai, Michael O Kurrer, Christian Rüedi, Michael B Brück, G Ulrich Exner
INTRODUCTION: Rarely solitary sternum metastases are addressed by resection. Two additional cases are presented as they are interesting because of their long-term follow-up. CASE PRESENTATION: Case 1: A renal cell carcinoma was treated by transabdominal nephrectomy at age 64. Right iliac bone and sternum metastases were diagnosed 7 months later and treated by internal hemipelvectomy followed by sternum metastasectomy 6 weeks after the internal hemipelvectomy. At 12-year follow-up, the patient appears disease free...
2024: Case Reports in Oncology
https://read.qxmd.com/read/38398232/impact-of-complete-surgical-resection-of-metastatic-lesions-in-patients-with-advanced-renal-cell-carcinoma-in-the-era-of-tyrosine-kinase-inhibitors-and-immune-checkpoint-inhibitors
#37
JOURNAL ARTICLE
Takuto Shimizu, Makito Miyake, Nobutaka Nishimura, Takanori Yoshida, Yoshitaka Itami, Akira Tachibana, Chihiro Omori, Yuki Oda, Mikiko Kohashi, Mitsuru Tomizawa, Kenta Onishi, Shunta Hori, Yosuke Morizawa, Daisuke Dotoh, Yasushi Nakai, Kazumasa Torimoto, Nobumichi Tanaka, Kiyohide Fujimoto
Complete metastasectomy (CM) in metastatic renal cell carcinoma (mRCC) has demonstrated efficacy in the cytokine era, but its effectiveness in the era of tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) remains unclear. A multi-institutional database included clinicopathological data of 367 patients with mRCC. Patients were divided into two groups: the CM group and the non-CM group. These two groups were compared before and after propensity score matching (PSM). Cox proportional hazard models were used to detect factors associated with disease-free survival (DFS) and overall survival (OS) from mRCC diagnosis...
February 19, 2024: Cancers
https://read.qxmd.com/read/38398154/adrenalectomy-for-metastasis-the-impact-of-primary-histology-on-survival-outcome
#38
JOURNAL ARTICLE
Mariaconsiglia Ferriero, Andrea Iannuzzi, Alfredo Maria Bove, Gabriele Tuderti, Umberto Anceschi, Leonardo Misuraca, Aldo Brassetti, Riccardo Mastroianni, Salvatore Guaglianone, Costantino Leonardo, Rocco Papalia, Michele Gallucci, Giuseppe Simone
Adrenalectomy is commonly considered a curative treatment in case of adrenal gland as site of metastasis. In the present study, we evaluated the impact of primary tumor histology on survival outcomes after a minimally invasive adrenal mastectomy for a solitary metachronous metastasis. From May 2004 to August 2020, we prospectively collected data on minimally invasive adrenalectomies whose pathological examination showed a metastasis. All patients only received metastasectomies that were performed with curative intent, or to achieve non-evidence of disease status...
February 13, 2024: Cancers
https://read.qxmd.com/read/38398093/pulmonary-metastasectomy-for-adrenocortical-carcinoma-not-if-but-when
#39
JOURNAL ARTICLE
Shamus R Carr, Frank Villa Hernandez, Diana Grace Varghese, Hyoyoung Choo-Wosoba, Seth M Steinberg, Martha E Teke, Jaydira Del Rivero, David S Schrump, Chuong D Hoang
BACKGROUND: Adrenocortical carcinoma (ACC) commonly metastasizes to the lungs, and pulmonary metastasectomy (PM) is utilized due to limited systemic options. METHODS: All ACC patients with initially only lung metastases (LM) from a single institution constituted this observational case series. Kaplan-Meier and Cox proportional hazard analyses evaluated the association with potential prognostic factors and outcomes. Overall survival (OS) was calculated from the date of the PM or, in those patients who did not undergo surgery, from the development of LM...
February 7, 2024: Cancers
https://read.qxmd.com/read/38387870/onyx%C3%A2-a-new-tool-for-intraoperative-localization-of-liver-lesions
#40
JOURNAL ARTICLE
J J Rubio-García, A J Mantilla Pinilla, S Gil Sánchez, C Villodre Tudela, C Alcázar López, P Melgar Requena, G Rodríguez Laiz, J Irurzun López, J M Ramia-Ángel
BACKGROUND: Precise preoperative localization of liver tumors facilitates successful surgical procedures, Intraoperative ultrasonography is a sensitive imaging modality. However, the presence of small non-palpable isoechoic intraparenchymal lesions may be challenging intraoperatively. METHODOLOGY AND MATERIAL DESCRIPTION: Onyx® is a non-adhesive liquid agent comprised of ethylene-vinyl alcohol usually used dissolved in dimethyl-sulfoxide and suspended micronized tantalum powder to provide contrast for visualization under fluoroscopy and ultrasonography and a macroscopic black shape...
February 22, 2024: Surgical Innovation
keyword
keyword
265
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.